Moldova Pharmaceuticals and Healthcare Report Q2 2009

Executive Summary .........5
SWOT Analysis...6
Moldova Pharmaceuticals And Healthcare Industry SWOT.. 6
Pharmaceutical Business Environment Ratings ......7
Table: Pharmaceutical Business Environment Ratings.......... 7
Limits To Potential Returns ......... 8
Risks To Realisation Of Returns ................ 8
Moldova - Market Summary ..........10
Regulatory Regime.........12
Intellectual Property Rights ....... 13
Pricing Regime ............ 13
Reimbursement Regime.............. 14
Table: Republic of Moldova - Out-of-pocket Payments for Healthcare ............. 14
International Trade Agreements .............. 15
Industry Developments..17
Epidemiology............... 17
Table: Republic of Moldova - Top 10 Causes of Death ....... 17
Table: Republic of Moldova – Leading Causes Of Morbidity As % of Total Disease Burden........ 18
Republic of Moldova - Acute Tuberculosis Morbidity ('000 population) ........... 19
Healthcare Sector ........ 20
Table: Republic of Moldova - Voluntary Health Insurance Indicators .............. 20
Primary Care............... 21
Secondary Care ........... 21
Compulsory Health Insurance ... 22
Table: Republic of Moldova – Social Health Insurance (SHI) Contributions By Source (As % Of Total) ................. 23
Table: Republic of Moldova – The Flat-Rate Contributions for Self-Insured/Per Capita Budget Contributions For The Unemployed. 23
Pharmaceutical Industry............ 24
Pharmaceutical Wholesale ........ 26
Pharmaceutical Retail ............... 26
Research and Development........ 27
Medical Devices........... 27
Industry Forecast Scenario ...........29
Overall Market Forecast............ 29
Table: Moldova – Drug Market Expenditure, 2003-2013 (MDLmn unless otherwise stated) ........ 30
Key Growth Factors – Industry................ 31
Table: Moldova – Health Expenditure, 2003-2013 (MDLmn unless otherwise stated).................. 32
Prescription Drug Market Forecast......... 33
Table: Moldova - Prescription Drug Market, 2003-2013 (MDLmn unless otherwise stated) ........ 34
Patented Drug Market Forecast .............. 35
Table: Moldova - Patented Drug Market, 2003-2013.......... 35
Generic Drug Market Forecast................ 36
Table: Moldova – Generic Drug Market, 2003-2013........... 37
OTC Drug Market Forecast....... 38
Table: Moldova – OTC Market, 2003-2013 (MDLmn unless otherwise stated)............... 39
Pharmaceutical Export/Import Forecast ............... 40
Table: Moldova – Pharmaceutical Trade Balance, 2003-2013 (US$mn) .......... 40
Other Healthcare Data Forecasts............ 41
Table: Moldova – Other Health Indicators, 2003-2013....... 41
Key Risks To BMI’s Forecasts ... 41
Competitive Landscape.42
Table: Republic Of Moldova – Top 10 Local Manufacturers (H107) ................ 43
Table: Republic Of Moldova – Top 10 Manufacturers By Value ......... 44
Table: Republic of Moldova – Top 10 Trade, INNs/Combinations And ATC Groups As Percentages Of Total Market Value (H108).. 45
Company Profiles...........46
Foreign Companies...... 46
Gedeon Richter ............ 46
Indigenous Companies............... 48
Farmaco ........ 48
Top Pharm..... 49
BMI Forecast Modelling.50
How We Generate Our Pharmaceutical Industry Forecasts 50
Pharmaceutical Business Environment Ratings Methodology ............. 51
Ratings Overview......... 51
Table: Pharmaceutical Business Environment Indicators ... 52
Weighting....... 53
Table: Weighting Of Components............ 53
Sources ............... 53